Do common TMPRSS6 variants lower iron indices and raise iron deficiency risk?

Variations in the TMPRSS6 gene are well-established genetic determinants of iron homeostasis. Scientific evidence robustly supports the association between common TMPRSS6 variants and reduced iron indices, which significantly elevates the risk of iron deficiency.

Clinical and Effectiveness Evidence

Research consistently identifies specific single nucleotide polymorphisms (SNPs) in the TMPRSS6 gene, most notably rs855791 (V736A), as critical regulators of iron status.

• Impact on Iron Indices: Genome-wide association studies (GWAS) demonstrate that individuals carrying the risk alleles (e.g., the C/T allele of rs855791) exhibit significantly lower serum iron, lower transferrin saturation (TSAT), and lower ferritin levels.
• Iron Deficiency Risk: These variants are associated with a dose-dependent increase in the risk of iron deficiency. In specific populations, such as pregnant women or those with higher physiological demands, homozygous risk-allele carriers may face a 2.5-fold to 6-fold increase in the odds of developing iron deficiency compared to those with the protective genotype.

Mechanistic Explanations

The TMPRSS6 gene encodes matriptase-2 (MT2), a protease that acts as the body’s primary "off switch" for hepcidin, the master iron-regulating hormone.

• Hepcidin Regulation: Under normal conditions of low iron, MT2 cleaves hemojuvelin (HJV) to prevent the production of hepcidin. The risk variants result in a less stable or less active MT2 protein.
• Inappropriate Hepcidin Elevation: Because the variant MT2 cannot efficiently suppress hepcidin, levels of this hormone remain inappropriately high even when iron stores are low.
• Absorption Blockade: Elevated hepcidin degrades ferroportin (the only known cellular iron exporter), thereby trapping iron inside intestinal cells and macrophages. This prevents dietary iron from entering the bloodstream, creating a functional "leak" in the body's iron supply.

Considerations for Marginal Intake

The impact of these genetic variants becomes most clinically significant when iron intake or absorption is already challenged.

• Reduced Absorption Efficiency: Isotope studies confirm that carriers of the TMPRSS6 risk variants have lower oral iron absorption efficiency.
• Compounding Factors: When dietary iron is marginal, the body’s natural compensatory mechanism—lowering hepcidin to maximize absorption—is genetically impaired. This makes individuals with these variants less resilient to low-iron diets or increased iron loss (e.g., menstruation), as they cannot "ramp up" absorption as effectively as those without the variant.

Bottom line

Common TMPRSS6 variants (like rs855791) are scientifically proven to lower iron indices and increase the risk of iron deficiency. This risk is amplified in scenarios of marginal iron intake because the genetic variant prevents the necessary suppression of hepcidin required to maximize dietary iron absorption.